Ramelmeier Rolf Andrew - Insider Non-Derivative Transactions at SANGAMO THERAPEUTICS, INC (SGMO) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on May 25, 2023, Ramelmeier Rolf Andrew's relationship to SANGAMO THERAPEUTICS, INC (SGMO) is Officer (EVP, Technical Operations) (EVP, Technical Operations), and currently has 171,467 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SGMO insiders.

Data Source: SEC.
Ramelmeier Rolf Andrew - Insider Non-Derivative Transactions of SGMO Common Stock
Mar 01Apr 01May 01050K100K150K200K
Ramelmeier Rolf Andrew - Insider Non-Derivative Transactions at SGMO
Date
Transaction
No. of Shares
Price Per Share
Shares Owned After Transactions
May 26, 2023 F -- (Common Stock) 1,750 1.33 171,467
Feb 26, 2023 F -- (Common Stock) 15,618 2.66 173,217
Feb 25, 2023 Acquisition -- (Common Stock) 45,000 0 188,835
Items per page:
1 – 3 of 3